This metabolite includes a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 about fifty% from the dad or mum drug. Plasma concentrations of the metabolite are somewhere around 40% of These witnessed for sildenafil, so the metabolite accounts for around 20% of sildenafil's pharmacologic outcomes.Beneath are a few mat